Advertisement
 
YOU ARE HERE: LAT HomeCollectionsMannatech Inc
IN THE NEWS

Mannatech Inc

MORE STORIES ABOUT:
FEATURED ARTICLES
CALIFORNIA | LOCAL
August 26, 1999 | From Bloomberg News
Mannatech Inc. has sued a former UC Irvine professor, alleging that research he published promoting the company's nutritional supplements contained false claims. The study by Dr. Darryl See, a former associate clinical professor at UCI's College of Medicine and a $10,000-a-month consultant for Mannatech, which is based in Coppell, Texas, ranked the company's pills in the top five of 196 nutritional supplements tested.
ARTICLES BY DATE
CALIFORNIA | LOCAL
August 26, 1999 | From Bloomberg News
Mannatech Inc. has sued a former UC Irvine professor, alleging that research he published promoting the company's nutritional supplements contained false claims. The study by Dr. Darryl See, a former associate clinical professor at UCI's College of Medicine and a $10,000-a-month consultant for Mannatech, which is based in Coppell, Texas, ranked the company's pills in the top five of 196 nutritional supplements tested.
Advertisement
CALIFORNIA | LOCAL
September 6, 1999 | KAREN ALEXANDER, TIMES STAFF WRITER
A former UC Irvine medical professor under investigation by the university has for the first time revealed the source of human blood samples he claims to have used in a controversial study. Through his lawyer, Dr. Darryl See of Laguna Niguel said the blood samples were obtained from patients at the Center for Special Immunology in Fountain Valley. See also said tests on the blood samples were performed at UCI during the time he was a faculty member at the school.
CALIFORNIA | LOCAL
August 5, 1999 | KAREN ALEXANDER, TIMES STAFF WRITER
UC Irvine officials are investigating whether a former medical school professor violated research-ethics rules for a recently published study about nutritional supplements--and are questioning whether he performed the work at all. Darryl See, 39, resigned from the UCI faculty in September 1998 after admitting he had violated research procedures, university officials said Wednesday.
Los Angeles Times Articles
|